AU750645B2 - Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH - Google Patents
Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH Download PDFInfo
- Publication number
- AU750645B2 AU750645B2 AU34428/99A AU3442899A AU750645B2 AU 750645 B2 AU750645 B2 AU 750645B2 AU 34428/99 A AU34428/99 A AU 34428/99A AU 3442899 A AU3442899 A AU 3442899A AU 750645 B2 AU750645 B2 AU 750645B2
- Authority
- AU
- Australia
- Prior art keywords
- carnitine
- acid
- alkanoyl
- camitine
- nadh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98RM000238A IT1299161B1 (it) | 1998-04-17 | 1998-04-17 | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph |
ITRM98A0238 | 1998-04-17 | ||
PCT/IT1999/000088 WO1999053921A1 (en) | 1998-04-17 | 1999-04-14 | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3442899A AU3442899A (en) | 1999-11-08 |
AU750645B2 true AU750645B2 (en) | 2002-07-25 |
Family
ID=11405812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU34428/99A Ceased AU750645B2 (en) | 1998-04-17 | 1999-04-14 | Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1071424A1 (xx) |
JP (1) | JP2002512191A (xx) |
KR (1) | KR20010042765A (xx) |
CN (1) | CN1299283A (xx) |
AU (1) | AU750645B2 (xx) |
BR (1) | BR9909712A (xx) |
CA (1) | CA2328331A1 (xx) |
EE (1) | EE200000601A (xx) |
HU (1) | HUP0101914A3 (xx) |
IL (1) | IL139014A0 (xx) |
IS (1) | IS5663A (xx) |
IT (1) | IT1299161B1 (xx) |
NO (1) | NO20005128L (xx) |
PL (1) | PL343482A1 (xx) |
SK (1) | SK15442000A3 (xx) |
TR (1) | TR200002894T2 (xx) |
WO (1) | WO1999053921A1 (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252309B2 (en) | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
DE10326822A1 (de) * | 2003-06-11 | 2005-01-05 | Herzpharma Vita-Check Diagnosegeräte GmbH | Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels |
AU2007353211B2 (en) * | 2007-05-11 | 2013-08-29 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of cosmetic active ingredients |
US20120214870A1 (en) * | 2009-08-31 | 2012-08-23 | University Of South Australia | Methods for diagnosis and treatment of chronic fatigue syndrome |
CN104306390A (zh) * | 2014-10-23 | 2015-01-28 | 苏州人本药业有限公司 | 还原型辅酶ⅱ的用途 |
CN104840479A (zh) * | 2015-02-17 | 2015-08-19 | 苏州人本药业有限公司 | Nadph在制备治疗心脏疾病药物中的应用 |
WO2019119445A1 (zh) * | 2017-12-22 | 2019-06-27 | 邦泰生物工程(深圳)有限公司 | 一种nadh复方组合物及其制剂和应用 |
DK3755160T3 (da) | 2018-04-20 | 2021-12-06 | Pacotrade Ag | Indretning til findeling af dybfrosne fødevarer, der forefindes i blokform |
CN109105702A (zh) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | 一种含有nadh的组合物、应用及能量补充剂的制备方法 |
CN109170907A (zh) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | 一种含有nmn的组合物、应用及运动饮料的制备方法 |
CA3115743A1 (en) * | 2018-10-10 | 2020-04-16 | So Ngor Sally LEUNG | Health-care product composition for enriching asthenic disease, preparation method therefor and use thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054698A (xx) * | 1964-12-04 | |||
DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
WO1997039749A2 (en) * | 1996-04-25 | 1997-10-30 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
JPH09110708A (ja) * | 1995-08-11 | 1997-04-28 | Taisho Pharmaceut Co Ltd | 滋養強壮用生薬配合製剤 |
JPH0959161A (ja) * | 1995-08-23 | 1997-03-04 | Taisho Pharmaceut Co Ltd | 疲労改善用組成物 |
IT1277953B1 (it) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
IT1283951B1 (it) * | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
JPH10175856A (ja) * | 1996-10-14 | 1998-06-30 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
-
1998
- 1998-04-17 IT IT98RM000238A patent/IT1299161B1/it active IP Right Grant
-
1999
- 1999-04-14 EP EP99916039A patent/EP1071424A1/en not_active Withdrawn
- 1999-04-14 TR TR2000/02894T patent/TR200002894T2/xx unknown
- 1999-04-14 BR BR9909712-5A patent/BR9909712A/pt not_active IP Right Cessation
- 1999-04-14 AU AU34428/99A patent/AU750645B2/en not_active Ceased
- 1999-04-14 SK SK1544-2000A patent/SK15442000A3/sk unknown
- 1999-04-14 PL PL99343482A patent/PL343482A1/xx not_active Application Discontinuation
- 1999-04-14 WO PCT/IT1999/000088 patent/WO1999053921A1/en not_active Application Discontinuation
- 1999-04-14 IL IL13901499A patent/IL139014A0/xx unknown
- 1999-04-14 CN CN99805644A patent/CN1299283A/zh active Pending
- 1999-04-14 KR KR1020007011499A patent/KR20010042765A/ko not_active Application Discontinuation
- 1999-04-14 CA CA002328331A patent/CA2328331A1/en not_active Abandoned
- 1999-04-14 JP JP2000544325A patent/JP2002512191A/ja active Pending
- 1999-04-14 EE EEP200000601A patent/EE200000601A/xx unknown
- 1999-04-14 HU HU0101914A patent/HUP0101914A3/hu unknown
-
2000
- 2000-10-12 NO NO20005128A patent/NO20005128L/no not_active Application Discontinuation
- 2000-10-13 IS IS5663A patent/IS5663A/is unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054698A (xx) * | 1964-12-04 | |||
DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
WO1997039749A2 (en) * | 1996-04-25 | 1997-10-30 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
Also Published As
Publication number | Publication date |
---|---|
CA2328331A1 (en) | 1999-10-28 |
IS5663A (is) | 2000-10-13 |
IL139014A0 (en) | 2001-11-25 |
EE200000601A (et) | 2002-04-15 |
EP1071424A1 (en) | 2001-01-31 |
HUP0101914A3 (en) | 2002-12-28 |
AU3442899A (en) | 1999-11-08 |
NO20005128L (no) | 2000-12-18 |
CN1299283A (zh) | 2001-06-13 |
ITRM980238A0 (it) | 1998-04-17 |
BR9909712A (pt) | 2000-12-26 |
WO1999053921A1 (en) | 1999-10-28 |
IT1299161B1 (it) | 2000-02-29 |
KR20010042765A (ko) | 2001-05-25 |
HUP0101914A2 (hu) | 2002-03-28 |
NO20005128D0 (no) | 2000-10-12 |
ITRM980238A1 (it) | 1999-10-17 |
PL343482A1 (en) | 2001-08-27 |
JP2002512191A (ja) | 2002-04-23 |
SK15442000A3 (sk) | 2001-06-11 |
TR200002894T2 (tr) | 2001-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0973415B1 (en) | Nutritional supplement | |
Abraham et al. | Management of fibromyalgia: rationale for the use of magnesium and malic acid | |
US8747906B2 (en) | Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose | |
US20120053240A1 (en) | Method of Administering beta-hydroxy-beta-methylbutyrate (HMB) | |
US20050271739A1 (en) | Methods and compositions for accelerating alcohol metabolism | |
AU4575299A (en) | Compositions for increasing energy (in vivo) | |
AU750645B2 (en) | Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH | |
US5994581A (en) | Carnitine creatinate | |
CZ20014077A3 (cs) | Doplňková výľiva dodávající energii kosternímu svalstvu a chránící kardiovaskulární systém | |
CA2400959C (en) | Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 | |
MXPA00009983A (en) | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph | |
US20020002202A1 (en) | Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia | |
CZ20003831A3 (cs) | Přípravek obsahující L-karnitin nebo alkanoyl Lkarnitinu a NADH a/nebo NADPH | |
AU2001241030A1 (en) | Composition for the prevention and/or treatment of vascular diseases, comprising propionyl L-carnitine and coenzyme Q10 | |
MXPA99008999A (en) | Nutritional supplement for facilitating skeletal muscle adaptation to strenuous exercise and counteracting defatigation in asthenic individuals | |
CZ347999A3 (cs) | Doplňková výživa pro snazší adaptaci kosterního svalstva vyčerpaného zatěžujícími výkony a paralyzování únavy asthenických jedinců |